Dr. Kampmann is an Associate Professor in the UCSF Department of Biochemistry and Biophysics and the Institute for Neurodegenerative Diseases, and an Investigator at the Chan Zuckerberg Biohub. He received his BA in Biochemistry from Cambridge University and his PhD in Biophysics/Cell Biology from Rockefeller University. The goal of Dr. Kampmann’s research is to elucidate cellular mechanisms of brain disease and to develop new therapeutic strategies. He co-developed the CRISPRi and CRISPRa screening technologies, and his lab has pioneered CRISPR-based functional genomics in cell types derived from induced pluripotent stem cells (iPSCs). A major focus is the investigation of neurodegenerative diseases in human iPSC-derived neurons, astrocytes, and microglia, and 3D assembloids/organoids. Dr. Kampmann was named an NIH Director’s New Innovator, an Allen Distinguished Investigator, a Chan Zuckerberg Biohub Investigator, and he received the CZI Ben Barres Early Career Acceleration Award.